Health TidingsKaryopharm Files sNDA for Selinexor Combination in Myelofibrosis Karyopharm Files sNDA for Selinexor Combination in Myelofibrosis Read Post »
Health TidingsSaroglitazar Hits Primary Endpoint in Zydus’ Phase II(b) MASH Trial Saroglitazar Hits Primary Endpoint in Zydus’ Phase II(b) MASH Trial Read Post »
Health TidingsTNX-103 Posts Strong Subgroup Results in PH-HFpEF Despite LEVEL Trial Miss TNX-103 Posts Strong Subgroup Results in PH-HFpEF Despite LEVEL Trial Miss Read Post »
Health TidingsAZD5462 Shows Early Effects in Phase IIb Heart Failure Trial AZD5462 Shows Early Effects in Phase IIb Heart Failure Trial Read Post »
Health TidingsFDA Expands Stelara to Pediatric Ulcerative Colitis FDA Expands Stelara to Pediatric Ulcerative Colitis Read Post »
Health TidingsFDA Approves Mounjaro (Tirzepatide) to Reduce Cardiovascular Risk in Adults... FDA Approves Mounjaro (Tirzepatide) to Reduce Cardiovascular Risk in Adults... Read Post »
Health TidingsBioNTech Ends Autogene Cevumeran CRC Trial, Pancreatic Trial Continues BioNTech Ends Autogene Cevumeran CRC Trial, Pancreatic Trial Continues Read Post »
Health TidingsMBX Biosciences Starts Phase 3 Trial of Once-Weekly Canvuparatide in Chroni... MBX Biosciences Starts Phase 3 Trial of Once-Weekly Canvuparatide in Chroni... Read Post »
Health Tidings Mergers & AcquisitionsDualityBio, Genentech Strike ADC Deal Worth More Than $1 Billion in Potenti... DualityBio, Genentech Strike ADC Deal Worth More Than $1 Billion in Potenti... Read Post »
Health TidingsPfizer-BioNTech XFG COVID-19 Vaccine Wins FDA Approval Pfizer-BioNTech XFG COVID-19 Vaccine Wins FDA Approval Read Post »
Health TidingsSOT106 Gets FDA Fast Track Designation for Soft Tissue Sarcoma SOT106 Gets FDA Fast Track Designation for Soft Tissue Sarcoma Read Post »
Health TidingsNatera, Angiex Expand Signatera ctDNA Monitoring in AGX101 Trial Natera, Angiex Expand Signatera ctDNA Monitoring in AGX101 Trial Read Post »
Health TidingsGenerate Biomedicines Discloses Early Release of Three GB-0895 Posters Ahea... Generate Biomedicines Discloses Early Release of Three GB-0895 Posters Ahea... Read Post »
Health TidingsAbbVie Seeks EMA Nod for Subcutaneous SKYRIZI in Crohn’s Disease AbbVie Seeks EMA Nod for Subcutaneous SKYRIZI in Crohn’s Disease Read Post »
Health TidingsGV101 Shows High Response Rates in Phase Ib/II Study of Chronic Graft-versu... GV101 Shows High Response Rates in Phase Ib/II Study of Chronic Graft-versu... Read Post »
Health TidingsZepbound Linked to Lower Healthcare Costs in Adults Over Age 55 With Obesit... Zepbound Linked to Lower Healthcare Costs in Adults Over Age 55 With Obesit... Read Post »
Health TidingsBausch Advances Dual-Action Dry Eye Drop to Phase 3 Despite Missing Phase 2... Bausch Advances Dual-Action Dry Eye Drop to Phase 3 Despite Missing Phase 2... Read Post »
Health TidingsMahzi Therapeutics Announces FDA Rare Pediatric Disease Designation for MZ-... Mahzi Therapeutics Announces FDA Rare Pediatric Disease Designation for MZ-... Read Post »
Health TidingsAirway Therapeutics Raises $50 Million to Advance Zelpultide Alfa in Bronch... Airway Therapeutics Raises $50 Million to Advance Zelpultide Alfa in Bronch... Read Post »
Health TidingsAbbott’s Libre Duo 10 Day Receives FDA Authorization for Continuous G... Abbott’s Libre Duo 10 Day Receives FDA Authorization for Continuous G... Read Post »
Health TidingsPeptron Advances PT403 Into Phase 1 Development as Once-Monthly Semaglutide... Peptron Advances PT403 Into Phase 1 Development as Once-Monthly Semaglutide... Read Post »
Health TidingsCaliway Advances CBL-514 With FDA-Cleared Tirzepatide Trial and Phase 3 Enr... Caliway Advances CBL-514 With FDA-Cleared Tirzepatide Trial and Phase 3 Enr... Read Post »
Health TidingsAstellas Advances ASP2138 Into Phase 3 Development for HER2-Negative Gastri... Astellas Advances ASP2138 Into Phase 3 Development for HER2-Negative Gastri... Read Post »
Health Tidings Mergers & AcquisitionsMcKesson to Acquire Precision Medicine Group for $2.25 Billion, Expanding C... McKesson to Acquire Precision Medicine Group for $2.25 Billion, Expanding C... Read Post »
Health TidingsCDSCO Expert Committee Recommends Bioequivalence and Phase III Trial Waiver... CDSCO Expert Committee Recommends Bioequivalence and Phase III Trial Waiver... Read Post »
Health TidingsErasca Granted FDA Fast Track Designation for ERAS-0015 in Metastatic Pancr... Erasca Granted FDA Fast Track Designation for ERAS-0015 in Metastatic Pancr... Read Post »
Health TidingsLEQEMBI IQLIK® (lecanemab-irmb) Autoinjector for Initiation and Maintenanc... LEQEMBI IQLIK® (lecanemab-irmb) Autoinjector for Initiation and Maintenanc... Read Post »
Health TidingsFDA Extends Deramiocel Review to November 2026 as Capricor Refines DMD Indi... FDA Extends Deramiocel Review to November 2026 as Capricor Refines DMD Indi... Read Post »
Health TidingsFDA Accepts United’s NDA for Ralinepag in Pulmonary Arterial Hypertension FDA Accepts United’s NDA for Ralinepag in Pulmonary Arterial Hypertension Read Post »
Health TidingsFDA Accepts Jemperli (Dostarlimab) for Priority Review in dMMR/MSI-H Locall... FDA Accepts Jemperli (Dostarlimab) for Priority Review in dMMR/MSI-H Locall... Read Post »
Health Tidings Mergers & AcquisitionsHanmi Pharm Signs Up to $2.3 Billion Genentech Deal for Obesity Candidate H... Hanmi Pharm Signs Up to $2.3 Billion Genentech Deal for Obesity Candidate H... Read Post »
Health TidingsSenju Advances SJP-0049 Into Phase III Trial in Japan for Allergic Conjunct... Senju Advances SJP-0049 Into Phase III Trial in Japan for Allergic Conjunct... Read Post »
GenericsZydus Secures USFDA Approval for Ascorbic Acid Injection for Scurvy Zydus Secures USFDA Approval for Ascorbic Acid Injection for Scurvy Read Post »
Health Tidings Mergers & AcquisitionsWerewolf Therapeutics and Ambros Therapeutics Merge to Advance Neridronate ... Werewolf Therapeutics and Ambros Therapeutics Merge to Advance Neridronate ... Read Post »
Health TidingsGossamer Secures Up to $250 Million to Advance Seralutinib Toward FDA Revie... Gossamer Secures Up to $250 Million to Advance Seralutinib Toward FDA Revie... Read Post »
Health TidingsMilestone Advances Etripamil into Phase 3 Trial for Acute AFib With Rapid V... Milestone Advances Etripamil into Phase 3 Trial for Acute AFib With Rapid V... Read Post »
Health TidingsNIH Awards $6.5 Million Grant to Advance Phase 3 PP-01 Trial in Cannabis Us... NIH Awards $6.5 Million Grant to Advance Phase 3 PP-01 Trial in Cannabis Us... Read Post »
Health TidingsRein Therapeutics Receives FDA Fast Track Designation for LTI-03 in Idiopat... Rein Therapeutics Receives FDA Fast Track Designation for LTI-03 in Idiopat... Read Post »
Health Tidings Mergers & AcquisitionsChai Discovery and Bristol Myers Squibb Partner to Advance AI-Driven Antibo... Chai Discovery and Bristol Myers Squibb Partner to Advance AI-Driven Antibo... Read Post »
Health TidingsNuvation Bio’s Safusidenib Receives FDA Fast Track Designation in IDH1-Mu... Nuvation Bio’s Safusidenib Receives FDA Fast Track Designation in IDH1-Mu... Read Post »
Health Tidings Mergers & AcquisitionsTolerance Bio Advances Efineptakin Alfa into Phase 2 Development for Thymic... Tolerance Bio Advances Efineptakin Alfa into Phase 2 Development for Thymic... Read Post »
Health TidingsFDA Details Clinical Evidence Supporting ASCENIV Expansion to Children Aged... FDA Details Clinical Evidence Supporting ASCENIV Expansion to Children Aged... Read Post »
GenericsGlenmark Wins U.S. FDA Approval for Fluticasone Propionate Nasal Spray Glenmark Wins U.S. FDA Approval for Fluticasone Propionate Nasal Spray Read Post »
Health TidingsKaliVir Raises $14 Million to Advance VET3-TGI in Phase 1/1b Solid Tumor Tr... KaliVir Raises $14 Million to Advance VET3-TGI in Phase 1/1b Solid Tumor Tr... Read Post »
Health TidingsFDA Accepts Teva’s NDA for Ecopipam with Priority Review for Pediatric To... FDA Accepts Teva’s NDA for Ecopipam with Priority Review for Pediatric To... Read Post »
Health TidingsConsano Bio’s C-1101 Wins FDA Fast Track for Chronic Sciatica Consano Bio’s C-1101 Wins FDA Fast Track for Chronic Sciatica Read Post »
Health Tidings Mergers & AcquisitionsFulcrum-Slate Merger Creates New Platform to Advance Next-Generation Migrai... Fulcrum-Slate Merger Creates New Platform to Advance Next-Generation Migrai... Read Post »
Health TidingsKynexis Advances KYN-5356 Toward Registrational Development in Schizophreni... Kynexis Advances KYN-5356 Toward Registrational Development in Schizophreni... Read Post »
Health Tidings Mergers & AcquisitionsIDEAYA and Genentech Partner to Evaluate IDE892 Plus GDC-7035 in PDAC IDEAYA and Genentech Partner to Evaluate IDE892 Plus GDC-7035 in PDAC Read Post »
Health TidingsAbcuro Raises $66M Series D for Ulviprubart IBM Phase 3 Trial Abcuro Raises $66M Series D for Ulviprubart IBM Phase 3 Trial Read Post »
